4//SEC Filing
Gentilcore Douglas J 4
Accession 0001415889-25-001877
CIK 0001722964other
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 7:03 PM ET
Size
5.9 KB
Accession
0001415889-25-001877
Insider Transaction Report
Form 4
Gentilcore Douglas J
SVP, Danyelza Bus. Unit Head
Transactions
- Award
Employee Stock Option (right to buy)
2025-01-17+142,600→ 142,600 totalExercise: $6.16Exp: 2035-01-17→ Common Stock (142,600 underlying)
Footnotes (2)
- [F1]Represents stock options granted to the Reporting Person pursuant to the Issuer's 2018 Equity Incentive Plan.
- [F2]The stock options shall vest and become exercisable as to 25% of the shares subject to the option on January 17, 2026, and thereafter vest and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
Documents
Issuer
Y-mAbs Therapeutics, Inc.
CIK 0001722964
Entity typeother
Related Parties
1- filerCIK 0002052524
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 7:03 PM ET
- Size
- 5.9 KB